Morgan Stanley says this pharma stock can rally more than 60% thanks to its narcolepsy treatment
- Posted on September 20, 2024
- By CNBC
- 1 Views
Morgan Stanley says this pharma stock can rally more than 60% thanks to its narcolepsy treatment
This stock could be at the forefront of a leading narcolepsy treatment that can send its shares soaring, according to Morgan Stanley.
